Endothelial cells: source, barrier, and target of defensive mediators.
Roumenina, Lubka T; Rayes, Julie; Frimat, Marie; Fremeaux-Bacchi, Veronique.
; 274(1): 307-329, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27782324
Primer komplementdefektusok által okozott atípusos haemolyticus uraemiás szindróma.
[Atypical HUS caused by complement-related abnormalities].
Atypical Hemolytic-Uremic Syndrome: A Clinical Review.
The clinical spectrum of hemolytic uremic syndrome secondary to complement factor H autoantibodies.
Von Willebrand factor regulates complement on endothelial cells.
Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?
Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.
Eculizumab use in kidney transplantation.